Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications from the Centre for Immuno-Oncology

MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution.

Journal article

Puttick C. et al, (2024), Nature genetics

CD137 (4-1BB) and T-Lymphocyte Exhaustion.

Journal article

Molero-Glez P. et al, (2024), Clin Cancer Res, OF1 - OF3

Cross-talk between ILC2 and Gata3high Tregs locally constrains adaptive type 2 immunity.

Journal article

Stockis J. et al, (2024), Science immunology, 9

Identification and structural characterization of a mutant KRAS-G12V specific TCR restricted by HLA-A3.

Journal article

Sim MJW. et al, (2024), European journal of immunology

Closing the equity gap in the treatment of HIV-2 infection.

Journal article

Rowland-Jones S. and Gea-Mallorquí E., (2024), The lancet. HIV, 11, e347 - e349

Double-stranded RNA to mimic viral infection for cancer immunotherapy.

Journal article

Martinez-Riaño A. et al, (2024), Clinical cancer research : an official journal of the American Association for Cancer Research

Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040.

Journal article

Melero I. et al, (2024), Annals of oncology : official journal of the European Society for Medical Oncology, 35, 537 - 548

Load More